Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results
PR Newswire —
Raising 2026 Innovation Target; Full Year 2026 Guidance of 4%-6% Organic Constant Currency Revenue Growth, 6%-9% Adjusted EBITDA Growth In Line with Investor Day Outlook Fourth Quarter 2025 Financial Results: Revenue of $1,144 million, increased 12% on a reported basis; 9% in organic...